Add like
Add dislike
Add to saved papers

Contemporary catheter ablation of complex atrial tachycardias after prior atrial fibrillation ablation: pulsed field versus radiofrequency current energy ablation guided by high-density mapping.

BACKGROUND: Catheter-ablation (CA) of post-ablation left-atrial tachycardias (LAT) can be challenging. So far, pulsed-field ablation (PFA) has not been compared to standard point-by-point radiofrequency-current (RFC) energy for LAT ablation.

AIMS: To compare efficacy of PFA versus RFC in patients undergoing CA for LAT.

METHODS: Consecutive patients undergoing LAT-CA were prospectively enrolled (09/2021-02/2023). After electro-anatomical high-density mapping, ablation with either a pentaspline PFA-catheter or RFC was performed. Patients were matched 1:1. Ablation was performed at the assumed critical isthmus site with additional ablation, if necessary. Right-atrial-tachycardia (RAT) were ablated with RFC. Acute and chronic success were assessed.

RESULTS: Fifty-six patients (n=28 each group, age 70 ± 9 years,75% male) were enrolled.A total of 77 AT (n=67 LAT, n=10 RAT; 77% macroreentries) occurred with n=32 LAT in the PFA- and n=35 LAT in the RFC-group. Of all LAT, 94% (PFA-group) vs. 91% (RFC-group) successfully terminated to sinus rhythm or another AT during ablation (p=1.0). Procedure times were shorter (PFA: 121 ± 41 vs. RFC: 190 ± 44 mins, p<0.0001) and fluoroscopy times longer in the PFA-group (PFA: 15 ± 9 vs. RFC: 11 ± 6mins, p=0.04). There were no major complications. After one-year follow-up, estimated arrhythmia-free survival was 63% (PFA-group) and 87% (RFC-group), (Hazard-Ratio 2.91 (95-%-CI: 1.11-7.65), p=0.0473).

CONCLUSION: PFA of post-ablation LAT using a pentaspline catheter is feasible, safe and faster but less effective compared to standard RFC ablation after one-year of follow-up. Future catheter-designs and optimization of the electrical field may further improve practicability and efficacy of PFA for LAT.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

Related Resources

For the best experience, use the Read mobile app

Mobile app image

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

By using this service, you agree to our terms of use and privacy policy.

Your Privacy Choices Toggle icon

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app